GRACEcast

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival


Listen Later

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

...more
View all episodesView all episodes
Download on the App Store

GRACEcastBy Howard (Jack) West, MD